Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein surface-exposed methionine residues are sulfur-containing amino acids located on the exterior of proteins, making them highly susceptible to oxidation by reactive oxygen species (ROS) to form methionine sulfoxide (MetO). Biologically, these residues serve as an endogenous antioxidant defense system, acting as sacrificial targets that protect the protein's hydrophobic core and critical functional sites from irreversible oxidative damage (Levine et al., 1996). This process is regulated by the methionine sulfoxide reductase (Msr) system, which enzymatically reduces MetO back to methionine, thereby maintaining protein function and cellular redox balance (Stadtman et al., 2003). In various pathologies, including neurodegenerative diseases like Alzheimer's and cardiovascular conditions, the accumulation of oxidized methionine residues is linked to protein misfolding and loss of activity (Ghesquière et al., 2011). While not a traditional single-protein drug target, surface methionines are critical in the pharmaceutical industry as critical quality attributes for biologics stability and are increasingly targeted for site-specific bioconjugation using novel chemoselective reagents like oxaziridines (Lin et al., 2017). Therapeutic interventions focus on enhancing the Msr repair pathway or utilizing methionine-selective chemistry for targeted drug delivery and proteomics.
Acts as a redox buffer through reversible oxidation to methionine sulfoxide; serves as a site for selective covalent labeling via electrophilic or redox-active reagents.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein surface-exposed methionine residues.